ANVISA RDCRDC 837/2023
RDC 837/2023 is ANVISA Collegiate Board Resolution 837/2023. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).
- Instrument
- RDC
- Full name
- Resolução da Diretoria Colegiada
- Category
- Clinical Trials
- Authority source
- Portuguese
- Readable HTML
- 81 articles · 1 language version
- Published
- December 15, 2023
- Effective
- December 15, 2023
Open a language version
Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Clinical Investigations with Medical Devices
Procedures and Good Clinical Practice requirements for clinical investigations with medical devices in Brazil whose results may support Class III and IV registration.
A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.